Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands
Authors:
- 1 May 2010
- journal article
- review article
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 18 (5) , 248-254
Abstract
In this part of a series on cardiogenetic founder mutations in the Netherlands, we review the Dutch founder mutations in hypertrophic cardiomyopathy (HCM) patients. HCM is a common autosomal dominant genetic disease affecting at least one in 500 persons in the general population. Worldwide, most mutations in HCM patients are identified in genes encoding sarcomeric proteins, mainly in the myosin-binding protein C gene (MYBPC3, OMIM #600958) and the beta myosin heavy chain gene (MYH7, OMIM #160760). In the Netherlands, the great majority of mutations occur in the MYBPC3, involving mainly three Dutch founder mutations in the MYBPC3 gene, the c.2373_2374insG, the c.2864_2865delCT and the c.2827C>T mutation. In this review, we describe the genetics of HCM, the genotype-phenotype relation of Dutch founder MYBPC3 gene mutations, the prevalence and the geographic distribution of the Dutch founder mutations, and the consequences for genetic counselling and testing. (Neth Heart J 2010;18:248-54.)Keywords
This publication has 79 references indexed in Scilit:
- A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South AsiaNature Genetics, 2009
- Diastolic Abnormalities as the First Feature of Hypertrophic Cardiomyopathy in Dutch Myosin-Binding Protein C Founder MutationsJACC: Cardiovascular Imaging, 2009
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseasesEuropean Heart Journal, 2007
- Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the AmishHeart, 2007
- Myozenin 2 Is a Novel Gene for Human Hypertrophic CardiomyopathyCirculation Research, 2007
- Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathyBiochemical and Biophysical Research Communications, 2006
- Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 geneJournal of Medical Genetics, 2006
- First description of germline mosaicism in familial hypertrophic cardiomyopathyJournal of Medical Genetics, 2000
- Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin GeneJACC, 1997
- Prognosis in hypertrophic cardiomyopathy observed in a large clinic populationThe American Journal of Cardiology, 1993